Skip to main content
CBIO logo

CBIO · Crescent Biopharma, Inc. · Executive Compensation

Track CBIO — free
$13.94 -0.38 (-2.65%)
Market Cap
$548.24M
Shares
37.14M
Volume · Oct 5 187.02K Avg daily vol (3M) 380.11K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Amy Reilly Appointed 2025-07-31
Rick Scalzo Appointed 2025-07-31
David Lubner Appointed 2025-07-31
Tanya Sengupta Appointed 2025-07-31
Jan Pinkas Appointed 2025-07-31
Joshua Brumm Appointed 2025-07-31
Jonathan McNeill Appointed 2025-07-31
Ellie Im Appointed 2025-07-31
Joshua Brumm Appointed 2025-07-31
Jonathan Violin Appointed 2025-06-18
Peter Harwin Appointed 2025-06-18
Susan Moran Appointed 2025-06-18
Joshua Brumm Appointed 2025-06-18
David Lubner Appointed 2025-06-18
Alexandra Balcom Appointed 2025-06-18
Barbara Bispham Appointed 2025-06-18
Ryan Lynch Appointed 2025-06-18
Peter Harwin Appointed 2025-06-18
Richard Scalzo Appointed 2025-06-18
Christopher Doughty Appointed 2025-06-18
Ellie Im Appointed 2025-06-18
Jonathan McNeill Appointed 2025-06-18
Joshua Brumm Appointed 2025-06-18
Brian Hahn Resigned 2025-06-18
Timothy Pearson Resigned 2025-06-18
Key facts CIK 1253689 CUSIP G2545C104 13F (30d) 2 filings 2 filers Visit website Investor relations